Galaxy Elbow

Product Highlights

Elbow Hinge

• To be used with 12mm rod for the humerus and 9mm rod for the ulna and the Galaxy Fixation™ clamps (please refer to the relevant operative technique)
• Radiolucent hinge that allows easy location of the center of rotation of the elbow, flexion-extension up to 175° and micrometric distraction (15mm) of the joint

Elbow Motion Unit

• To be used with the elbow hinge for passive motion
• Allows controlled, limited flexion/extension of the joint

Benefits to Surgeon

• Radiolucent hinge that allows easy location of the center of rotation of the elbow, flexion-extension and micrometric distraction
• Fast and easy assembly
• Flexibility of use (ease of use)
• Versatile sterile kits, sterile single packed components, instrument and implant trays
• Clamps for independent screw placement
• Allows easy and stable connection of either a rod and a bone screw or two rods
• Places screws where the condition of the bone and soft tissues permits

Benefits to Patient

• Non-invasive targeting technique
• Cylindrical self-drilling bone screws with 4 and 5mm thread diameters to fit pediatric anatomy appropriately
• Allows either free or controlled/limited flexion-extension of the joint

Indications

• Infected and aseptic nonunions
• Joint pathologies/injuries of upper and lower limb, such as:
  • Delayed treatment of dislocated and stiff elbows
  • Chronic, persistent elbow joint instability
  • Acute elbow joint instability after complex ligament injuries
  • Unstable elbow fractures
  • Additional elbow stabilization of post-operative unstable internal fixation

Contraindications

DO NOT USE the Galaxy Fixation device if a surgical candidate exhibits or is predisposed to any of the following contraindications:

• Mental or physiological conditions and who are unwilling or incapable of following postoperative care instructions
• Severe osteoporosis*
• Severe, poorly controlled diabetes mellitus
• Compromised vascularity
• Previous infections
• Malignancy in the fracture area
• Neuromuscular deficit or any other conditions that could influence the healing process
• HIV positive
• Suspected or documented metal sensitivity reactions as it could result in a treatment failure in the intended population.

*As defined by the World Health Organization: Bone mineral density of 2.5 standard deviations or more below the mean peak bone mass (average of young, healthy adults) in presence of one or more fragility fractures.